Neuroendocrine tumors g3 cannot be cured, but some remission can be achieved through comprehensive treatment mainly by surgery.
According to the Ki-67 index and nuclear schizophrenia, neuroendocrine tumors can be classified into 3 grades, namely g1, g2 and g3, and their malignant degree is in the order of g3>g2>g1. The higher the Ki-67 index and nuclear schizophrenia indicate that the tumor grows faster. For patients with Ki-67 index ≤55%, surgical treatment is effective.
For patients with Ki-67 index ≤55%, small tumor load or tumor shrinkage or downstaging after aggressive conversion therapy, and estimated to be radically resectable, surgical treatment can be considered.
For patients with Ki-67 index >55%, large tumor load, and incapable of radical resection, surgery is not advocated, and platinum-based drug chemotherapy, such as cisplatin, etoposide, etc., is recommended, and the drugs are administered in accordance with the doctor’s instructions, but hematopoietic adverse reactions such as leukocyte decline may occur.
The treatment of g3 depends on a variety of factors, such as tumor stage, primary site, differentiation, proliferation and molecular expression. As there are few prospective studies for g3, there is no definitive treatment. In addition to surgery and chemotherapy, targeted therapy and immunotherapy can also be used under the guidance of doctors.
Please strictly follow the doctor’s instructions for drug treatment, and do not self-medicate.